The Power of Three for Hybrid Imaging

 
June 29, 2006

SceptreP3 is a hybrid PET/CT system that integrates the “Power of Three” suite of differentiating capabilities.

SceptreP3’s Dual Attenuation Correction (DAC) technology reportedly allows the combination of both CT and sealed-source attenuation correction to effectively image patients with metal implants. The Non-Rigid Fusion7D algorithm provides registration by correcting for respiration differences between PET and CT acquisitions, and the integration of the AVIA-PACS architecture improves software communication, multimodal connectivity and supports RAID archiving capabilities, said the company.

Featuring fast LSO PET and the Hitachi CT platform, SceptreP3 reportedly offers a new level of integration, connectivity and straightforward operation that delivers clinical results where and when they are needed.

More like this

The content of this field is kept private and will not be shown publicly.
By submitting this form, you accept the Mollom privacy policy.

Related News

Bayer Enters Agreement to Expand Markets for Medrad Intego PET Infusion System

March 5, 2013 - Bayer Healthcare is expanding its global distribution network for the Medrad Intego positron emission tomography (PET) Infusion System through a new distribution agreement with...

Hybrid Imaging: The Best of Both Worlds

The introduction of hybrid technology — positron emission tomography/computed tomography (PET/CT) and single-photon emission computed tomography (SPECT)/CT -— has...

Manhattan Isotope Starts Formal Process to Produce Sr-82

August 27, 2012 — Positron Corp., a molecular imaging healthcare company, announced the submission of a drug master file (DMF) with the U.S. Food and Drug Administration (FDA) for the production...

View all

Related Articles

Hybrid Imaging: The Best of Both Worlds

The introduction of hybrid technology — positron emission tomography/computed tomography (PET/CT) and single-photon emission computed tomography (SPECT)/CT -— has...

Manhattan Isotope Starts Formal Process to Produce Sr-82

August 27, 2012 — Positron Corp., a molecular imaging healthcare company, announced the submission of a drug master file (DMF) with the U.S. Food and Drug Administration (FDA) for the production...

Enhancing Cardiac Nuclear Imaging

There are currently three major trends in cardiac nuclear perfusion imaging technology: advances in detector hardware, improved software and new radiotracers. These advances have enhanced the...

View all